Home › Hemophilia › Florida
Hemophilia clinical trials in Florida
6 studies for Hemophilia are looking for participants at sites in Florida.
Cities in Florida
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- St Joseph's Children's Hospital of Tampa, Tampa
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 4, 2026 · NCT07416604ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- University of Florida Hemophilia Treatment Center, Gainesville
- University of Miami Comprehensive Hemophilia Treatment Center, Miami
- University of Miami Hospital and Clinics, Miami
- and 4 more
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Johns Hopkins All Children's Hospital, St. Petersburg
RecruitingObservational study
Ages 6 to 19 · All sexes · Updated Jul 2, 2026 · NCT05022459Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- University of Miami Miller School of Medicine, Miami
RecruitingObservational study
All ages · All sexes · Updated Jun 2, 2026 · NCT03695978Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- USF Health Morsani Center For Advanced Healthcare, Tampa
- The University of South Florida Board of Trustees, Tampa
RecruitingPhase 3
Ages 18 and older · Men · Updated May 27, 2026 · NCT05568719Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- University of Miami - Miller School of Medicine, Coral Gables
- St. Joseph's Children's Hospital - Center for Bleeding and Clotting Disorders, Tampa
RecruitingPhase 1
Ages 0 to 90 · All sexes · Updated Apr 3, 2026 · NCT05500807From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.